SecBot SecBot
SECBOTREPLAY Home › Report › GSK

GSK · GSK filed a routine 6-K disclosing weekly share repurchases under its…

GSK plc · 6-K filed Jun 15, 2026 at 10:02 ET

At the news

NEUTRALIMPACT 3/10

6-K filed Jun 15, 2026 at 10:02 ET

GSK filed a routine 6-K disclosing weekly share repurchases under its existing buyback program. The company bought ~1.1M shares over five days in June 2026 at an average price of ~1,930 GBp, continuing the program announced on May 11, 2026. This is a standard periodic update with no new strategic or financial information.

  • Purchased 225,237 shares on June 8, 228,524 on June 9, 222,449 on June 10, 220,242 on June 11, and 215,972 on June 12, 2026.
  • Volume-weighted average prices ranged from 1,882.23 GBp to 1,983.00 GBp per share.
  • Since May 11, 2026, GSK has repurchased a total of 7,346,236 ordinary shares.
  • After these purchases, GSK holds 268,724,522 shares in treasury (6.64% of voting rights) and has 4,047,527,077 shares in issue (excluding treasury).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access